These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24660566)
1. An unusual case of invasive Aspergillus ulcerative tracheobronchitis without involvement of lung parenchyma in a post-renal transplant patient. Tilve SS; Shah AB; Prabhudesai PP; Tampi C Indian J Chest Dis Allied Sci; 2013; 55(4):221-3. PubMed ID: 24660566 [TBL] [Abstract][Full Text] [Related]
2. [Aspergillus tracheobronchitis in a lung transplant recipient]. García-Gallo CL; García-Fadul C; Laporta-Hernández R; Ussetti-Gil P Rev Iberoam Micol; 2011; 28(3):129-33. PubMed ID: 21700233 [TBL] [Abstract][Full Text] [Related]
3. Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis. Solak Y; Atalay H; Nar A; Ozbek O; Turkmen K; Erekul S; Turk S Transpl Infect Dis; 2011 Apr; 13(2):178-81. PubMed ID: 20738834 [TBL] [Abstract][Full Text] [Related]
4. Ulcerative tracheobronchitis due to Aspergillus. Dominelli GS; Shaipanich T J Bronchology Interv Pulmonol; 2013 Oct; 20(4):326-9. PubMed ID: 24162116 [TBL] [Abstract][Full Text] [Related]
5. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient. Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380 [TBL] [Abstract][Full Text] [Related]
6. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Kramer MR; Denning DW; Marshall SE; Ross DJ; Berry G; Lewiston NJ; Stevens DA; Theodore J Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):552-6. PubMed ID: 1654038 [TBL] [Abstract][Full Text] [Related]
7. Radiological resolution of cavitating Aspergillus fumigatus infection following treatment with oral voriconazole in two lung transplant recipients. Zoumot Z; Carby M; Hall AV Transpl Int; 2006 Aug; 19(8):688-90. PubMed ID: 16827687 [No Abstract] [Full Text] [Related]
8. Ulcerative pseudomembranous tracheobronchitis caused by Aspergillus fumigatus. Ariza-Prota M; Morales-Soto A; Rosell-Grataços A Arch Bronconeumol; 2016 Aug; 52(8):436-7. PubMed ID: 26497417 [No Abstract] [Full Text] [Related]
9. Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients. Veroux M; Corona D; Gagliano M; Sorbello M; Macarone M; Cutuli M; Giuffrida G; Morello G; Paratore A; Veroux P Transplant Proc; 2007; 39(6):1838-40. PubMed ID: 17692627 [TBL] [Abstract][Full Text] [Related]
10. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215 [TBL] [Abstract][Full Text] [Related]
11. Late aspergilloma of a renal allograft without need for operative management: a case report and review of the literature. Shannon EM; Reid MJ; Chin-Hong P Transpl Infect Dis; 2016 Apr; 18(2):261-5. PubMed ID: 26751414 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis. Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811 [TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Belgium. Selleslag D; Vogelaers D; Marbaix S Acta Clin Belg; 2009; 64(5):393-8. PubMed ID: 19999386 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338 [TBL] [Abstract][Full Text] [Related]
15. Pseudomembranous tracheobronchitis caused by Aspergillus in immunocompromised patients. Chang SM; Kuo HT; Lin FJ; Tzen CY; Sheu CY Scand J Infect Dis; 2005; 37(11-12):937-42. PubMed ID: 16308239 [TBL] [Abstract][Full Text] [Related]
16. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole. Neoh CF; Leung L; Vajpayee RB; Stewart K; Kong DC Ann Pharmacother; 2011 May; 45(5):e24. PubMed ID: 21521864 [TBL] [Abstract][Full Text] [Related]
18. Report of 38 cases of tracheobronchitis in non-immunocompromised patients with dual isolation of Aspergillus in lower respiratory tract samples. Barberán J; Sánchez-Haya E; del Castillo D; Sanz F; Alcázar B; Malmierca E; Rev Esp Quimioter; 2014 Jun; 27(2):110-4. PubMed ID: 24940892 [TBL] [Abstract][Full Text] [Related]